Last reviewed · How we verify
BD111 Adult single group Dose — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BD111 Adult single group Dose (BD111 Adult single group Dose) — Shanghai BDgene Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BD111 Adult single group Dose TARGET | BD111 Adult single group Dose | Shanghai BDgene Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BD111 Adult single group Dose CI watch — RSS
- BD111 Adult single group Dose CI watch — Atom
- BD111 Adult single group Dose CI watch — JSON
- BD111 Adult single group Dose alone — RSS
Cite this brief
Drug Landscape (2026). BD111 Adult single group Dose — Competitive Intelligence Brief. https://druglandscape.com/ci/bd111-adult-single-group-dose. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab